We generate over 4,000 proprietary deal leads per year
Exclusive customized deals for our clients are not in this list. Please contact us with the Deal ID if you are interested in any specific opportunity
Date  |
Deal ID |
Sector |
Deal Type |
Deal Currency |
Revenue |
Deal Size |
| 21/06/2018 |
14609 |
Business Service |
Private Placement |
RMB / USD |
RMB 100 m |
RMB 150 m |
- Private company developing intelligent parking lot management software systems
- Raised fund of RMB 150m with valuation RMB 1b; prefer investors with parking lot business resources or investment experiences in travelling field
- Revenue 2017 RMB 30m and expected to be RMB 100m in 2018
- Covered 1,500 parking lots in China and plans to develop 5,000 new in 2019
- Pre-system and follow-up services account for about 60% and 40% of current revenue
Become Client
Learn More
| 21/06/2018 |
14672 |
Healthcare |
Private Placement |
RMB / USD |
N/A |
RMB 146 m |
- Private company engaged in R&D of innovative anti-tumor drugs
- Launching series A round funding of USD 20m to USD 25m
- Prefer USD funds
- Focus on regulation of T cell immune function
Become Client
Learn More
| 21/06/2018 |
14671 |
Industrials |
Private Placement |
RMB / USD |
N/A |
RMB 150 m |
- Hangzhou-based private company that develops and manufactures intelligent electric vehicles
- Launching series A round funding of RMB 1b to RMB 2b
- Prefer investors with industrial backgrounds or well-known financial institutions
Become Client
Learn More
| 21/06/2018 |
14670 |
Consumer |
Private Placement / M&A |
RMB / USD |
RMB 200 m |
N/A |
- Ecommerce operating household goods
- Considering strategic investment or selling controlling stake
- Revenue 2017 RMB 100m with net profit RMB 5m; revenue 2018 expected to be RMB 200m with net profit RMB 15m
- Main products cover over 10 categories including towels, underwear, socks, etc.
- Online sales 90%, offline 6%, and corporate customer 4%
Become Client
Learn More
| 20/06/2018 |
14668 |
Consumer |
Private Placement |
RMB / USD |
RMB 400 m |
RMB 150 m |
- Braised prawns restaurant chain
- Launch series B round funding of RMB 150m
- Expected revenue 2018 RMB 400m, with net profit of over RMB 70m
- Have over 40 directly-operated stores
Become Client
Learn More
| 20/06/2018 |
14666 |
Business Service / TMT |
Private Placement |
RMB |
RMB 80 m |
RMB 100 m |
- Private company that provides intelligent big data risk control platforms for financial and government institutions
- Launching series A+ round funding with the sale of 5% to 10% stake and plan to launch series B round funding of at least RMB 100m after the Spring Festival in 2019
- Revenue 2017 RMB 35m; expected revenue 2018 RMB 80m with net profit RMB 10m to RMB 20m
Become Client
Learn More
| 20/06/2018 |
14665 |
Business Service / Consumer |
Private Placement |
RMB |
RMB 18 m |
RMB 30 m |
- Private company providing running-related and event management services for runners and race service providers
- Launching A+ round funding of nearly RMB 30m with the sale of over 10% stake
- Main revenue comes from equipment fees, online and offline advertising fees and event service fees
- Revenue 2017 nearly RMB 9m; revenue 2018 expected to double and the company will be profit-making
Become Client
Learn More
| 20/06/2018 |
14664 |
Consumer |
Private Placement |
RMB / USD |
RMB 1000 m |
N/A |
- Private company engaged in R&D, production and marketing of freeze-dried food
- Considering minority funding and the chairman hold the controlling position
- Plan to go public in the A-share market in China
- Total revenue RMB 1b, of which RMB 700m to RMB 800m from the agent processing business and the rest own-brand sales
- The main business freeze-dried food processing and independent brand products
Become Client
Learn More
| 20/06/2018 |
14663 |
Healthcare |
Private Placement |
RMB / USD |
N/A |
RMB 300 m |
- Taizhou-based private company focusing on R&D of innovative drugs in areas of anti-tumor and drug-resistant infection
- Launch pre-IPO funding of over RMB 300m in July to August
- Plan to go public in Hong Kong
- Prefers USD funds
- Focuse on bladder cancer and other genitourinary tumors, tumor immunotherapy, and multi-drug resistant infection
Become Client
Learn More
| 20/06/2018 |
14662 |
Consumer |
M&A |
RMB / USD |
RMB 200 m |
N/A |
- Hangzhou-based private company providing real-time risk control, anti-fraud and credit products to financial institutions
- Consider strategic funding in 2019 with the sale of 10% stake
- Prefer RMB investors with strategic resources
- Services include banking, Internet finance, e-commerce travel, etc.
Become Client
Learn More
| 20/06/2018 |
14661 |
Business Service / TMT |
Private Placement |
RMB |
N/A |
N/A |
- Hangzhou-based private company providing real-time risk control, anti-fraud and credit products to financial institutions
- Consider strategic funding in 2019 with the sale of 10% stake
- Prefer RMB investors with strategic resources
- Services include banking, Internet finance, e-commerce travel, etc.
Become Client
Learn More
| 20/06/2018 |
14659 |
Healthcare |
Private Placement / M&A |
USD |
N/A |
RMB 650 m |
- Private company engaged in the development of new drugs for cancer antibody coupling
- Launching pre-IPO funding of USD 100m in the first quarter of 2019
- Prefer to go public in Hong Kong, but also consider NASDAQ
- Received milestone payments and royalties of USD 250m and will receive an overall income of USD 1.4b
Become Client
Learn More
| 20/06/2018 |
14658 |
Healthcare |
Private Placement |
RMB / USD |
N/A |
RMB 65 m |
- Private company engaged in R&D of new drugs in uric acid metabolism and gout attack inflammatory disease
- Series A round funding of USD 10m about to close
- Accepting institutions who can make quick decisions
- Plan to go public on NASDAQ after series A round funding
Become Client
Learn More
| 20/06/2018 |
14656 |
Healthcare |
Private Placement |
RMB / USD |
RMB 30 m |
RMB 100 m |
- High-tech company engaged in R&D and production of molecular diagnostic products
- Launch funding of over RMB 100m in late 2018 with post-investment valuation nearly RMB 1b and sale of 10% to 15% stake
- Revenue 2017 nearly RMB 10m and expected to reach RMB 30m in 2018
- Revenue mainly from clinical tumor detection
Become Client
Learn More
| 20/06/2018 |
14655 |
Business Service / Industrials |
Private Placement |
RMB / USD |
N/A |
RMB 100 m |
- Private company that develops and sells binocular ADAS products
- About to close series B1 and B2 round funding of a total of RMB 200m and will launch B3 round funding of over RMB 100m in the fourth quarter of 2018
Become Client
Learn More
| 20/06/2018 |
14653 |
Business Service / Industrials |
Private Placement |
RMB / USD |
RMB 30 m |
RMB 50 m |
- Private company focusing on robot autonomous mobile solutions and robotics applications
- Launching series A round funding of RMB 50m with overall valuation RMB 500m
- Revenue 2018 expected to reach RMB 30m
- Main products warehousing and transportation robot, autonomous transportation robot, autonomous mobile robot, and navigation robot
Become Client
Learn More
| 20/06/2018 |
14639 |
Consumer |
Private Placement |
RMB / USD |
N/A |
N/A |
- Zhejiang-based ecommerce platform operating community fresh food distribution services
- Launching series C round funding
- USD funds preferred
- Business model based on location based service (LBS)
- Have two service models: local life service and group purchasing
Become Client
Learn More
| 20/06/2018 |
14649 |
Healthcare |
Private Placement |
RMB / USD |
N/A |
RMB 100 m |
- Private company focusing on R&D of innovative chemical drugs
- Launch a new round of funding of over RMB 100m in 2019
- Was a CRO company focusing on R&D of new drugs and began to independently develop new drugs from 2014
- Sales 2017 over RMB 3m
Become Client
Learn More
| 20/06/2018 |
14654 |
Consumer |
Private Placement |
RMB / USD |
N/A |
RMB 200 m |
- E-commerce platform operating online fresh food ordering and distribution
- Launching series B round funding of RMB 200m
- Main products fresh fruit, selected seafood, meat and poultry, vegetables, snacks and beverages, etc.
- Self-operate cold chain logistics, self-build warehousing and control temperature and humidity throughout distribution
Become Client
Learn More
| 19/06/2018 |
14643 |
Industrials |
Private Placement / M&A |
RMB / USD |
RMB 2000 m |
N/A |
- Tianjin-based private company that develops, designs and manufactures security monitoring products and provides relevant solutions
- Prefer selling strategic or controlling stake and will not consider pure financial investment; also plan to go public
- Revenue 2017 over RMB 2b
- Main products network cameras, ball machines, display and control equipment, transmission and decoding equipment, back end storage equipment, transportation products, and platform products
Become Client
Learn More
